MedPath

SAIZEN

SAIZEN

Approved
DIN Number

02350130

Drug Class

Human

Market Date

Dec 2, 2010

Company
HC

emd serono, a division of emd inc., canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02350130
AIG Number0131827013
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
H01AC01 SOMATROPIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:28.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SOMATROPINActive
Strength: 8 MG / ML
Monograph: SOMATROPIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.